BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| 6-Methyldiosgenin Acetate | 6-Methyldiosgenin Acetate, an intriguing biomedicine, holds significant promise for treating a myriad of diseases. Renowned for its remarkable anti-inflammatory, anti-cancer, and anti-microbial attributes, this compound garners attention from healthcare enthusiasts. 6-Methyldiosgenin acetate is a saponin that is found in the plant Balanites aegyptiaca. Alternative Names: (25R)-6-Methylspirost-5-en-3beta-ol acetate; 6-Methylspirost-5-en-3-yl acetate. CAS No. 6877-73-2. Molecular formula: C30H46O4. Mole weight: 470.68. |  |
| 6-Methylpseudouridine | 6-Methylpseudouridine is a powerful and discerning antiviral compound, boasting remarkable efficacy in the research of notorious RNA viruses like the Zika virus and hepatitis C. Alternative Names: 2,4(1H,3H)-Pyrimidinedione, 6-methyl-5-β-D-ribofuranosyl-; 6-Methyl-5-beta-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione. Grades: ≥95%. CAS No. 1613530-10-1. Molecular formula: C10H14N2O6. Mole weight: 258.23. | |
| 6-Methylpurine 2'-deoxyriboside | It's a prodrug of the anticancer agent 6-methylpurine, and it is used in gene therapy. Alternative Names: 6-Methylpurine-2'-deoxy-beta-D-riboside; MePdR; 9-(2-Deoxy-β-D-erythropentofuranosyl)-6-methyl-9H-purine; (2R,3S,5R)-2-(Hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3-ol; NSC 103543; 9-(2-Deoxy-beta-D-ribofuranosyl)-6-methyl-9H-purine. Grades: ≥95%. CAS No. 16006-64-7. Molecular formula: C11H14N4O3. Mole weight: 250.25. | |
| 6-Methylpurine-b-D-(3-azido-3-deoxy)riboside | 6-Methylpurine-b-D-(3-azido-3-deoxy)riboside is a profoundly efficacious antiviral compound, displaying its prowess by curbing the replication of RNA viruses via its targeted interaction with the viral RNA-dependent RNA polymerase. Alternative Names: 6-Methylpurine-β-D-(3-azido-3-deoxy)riboside. Grades: ≥95%. CAS No. 2095417-25-5. Molecular formula: C11H13N7O3. Mole weight: 291.27. | |
| 6-Methylthio-GDP | 6-Methylthio-GDP, an intriguing nucleotide analog, is well-known for its application in synthesizing RNA and DNA. Capable of impeding RNA polymerase activity, this compound has been explored as a promising candidate for anti-cancer drugs. Furthermore, its antiviral activity against selective RNA viruses has been demonstrated. These properties render it an essential compound in biomedicine research. Alternative Names: 6-Methylthioguanosine-5'-diphosphate, Sodium salt. Grades: ≥ 95% by HPLC. Molecular formula: C11H17N5O10P2S (free acid). Mole weight: 473.29 (free acid). | |
| 6-Methylthio-GMP | 6-Methylthio-GMP, a highly potent nucleotide analog, exhibits remarkable efficacy against diverse viral infections and several cancers. This promising molecule significantly interferes with DNA synthesis, thereby repressing tumor growth and inhibiting viral replication. Moreover, cutting-edge research indicates its potential for treating inflammation. Alternative Names: 6-Methylthioguanosine-5'-monophosphate, Sodium salt. Grades: ≥ 95% by HPLC. Molecular formula: C11H16N5O7PS (free acid). Mole weight: 393.31 (free acid). | |
| 6-Methylthio-GTP | 6-Methylthio-GTP, a pivotal determinant in the bio-mechanisms modulating GTPase activity, renders itself an irreplaceable asset for biomedical studies analyzing post-translational modifications. By examining its interactions with effectors proteins in the context of diseases spanning from cancer to neurodegenerative disorders, this compound furthers our understanding of the intricate workings of the human body and aids in the fight against various ailments. Alternative Names: 6-Methylthioguanosine-5'-triphosphate, Sodium salt. Grades: ≥ 95% by HPLC. CAS No. 70318-62-6. Molecular formula: C11H18N5O13P3S (free acid). Mole weight: 553.27 (free acid). | |
| 6-Methyl-thio-guanosine | 6-Methyl-thio-guanosine is a remarkable biomedical concoction widely employed as a nucleoside analog in research of viral infestations, namely hepatitis C and influenza. Displays a formidable arsenal of antiviral capabilities, it efficaciously impedes viral recompoundion through its assimilation into the viral RNA strand, thereby forestalling the intricate process of enhancement. Alternative Names: 2-Amino-6-methythio-9-(beta-D-ribofuranosyl)-9H-purine; 9H-Purin-2-amine, 6-(methylthio)-9-beta-D-ribofuranosyl-; 6-Methylthioguanosine; (2R,3R,4S,5R)-2-(2-amino-6-(methylthio)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 2-Amino-6-methylthiopurine ribonucleoside. Grades: ≥95%. CAS No. 4914-73-2. Molecular formula: C11H15N5O4S. Mole weight: 313.33. | |
| 6-Methylthio-guanosine | 6-Methylthio-guanosine, a petite molecule, offers a vantage point for investigating the intricate interplay between post-transcriptional modification and gene expression. Its structural resemblance to S-adenosylmethionine, along with a demonstrated impact on mRNA transcript stabilization and translation regulation, hold immense value for scientific investigations. Furthermore, its potential therapeutic applications in treating viral infections and cancer open up new avenues of exploration for the scientific community. Grades: ≥ 98%. Molecular formula: C11H15N5O4S. Mole weight: 313.33. | |
| 6-Methylthio-IDP | 6-Methylthio-IDP is a pharmacologically powerful compound, exhibiting robust antiviral properties against a diverse range of viral pathogens, such as HIV / AIDS. Its mechanism of action involves impeding the viral replication cycle, thereby circumventing compound-resistant strains. Alternative Names: 6-Methylthioinosine-5'-diphosphate, Sodium salt; 6-Methylmercapto-9-(β-D-ribofuranosyl)purine-5'-diphosphate. Grades: ≥ 95% by HPLC. Molecular formula: C11H16N4O10P2S (free acid). Mole weight: 458.27 (free acid). | |
| 6-Methylthio-IMP | 6-Methylthio-IMP is an antimetabolite that inhibits de novo purine synthesis. It exhibits an antitumor effect in vivo. Alternative Names: 6-Methylthioinosine-5'-monophosphate, Triethylammonium salt; 6-Methylmercapto-9-(β-D-ribofuranosyl)purine-5'-monophosphate. Grades: ≥ 95% by HPLC. CAS No. 7021-52-5. Molecular formula: C11H15N4O7PS (free acid). Mole weight: 378.29 (free acid). | |
| 6-Methylthio-inosine | 6-Methylthio-inosine, a compound utilized in the biomedical sphere to heal cardiac ailments, has the unique ability to restrain enzymes implicated in purine metabolism. Its medicinal properties do not end there; research has also uncovered its potential in battling malignant tumors, such as leukemia and breast cancer. Grades: ≥ 98%. Molecular formula: C11H14N4O4S. Mole weight: 298.31. | |
| 6-Methylthio-ITP | 6-Methylthio-ITP, a small molecule with potential biomedical significance, is utilized in the scientific investigation of purinergic signaling with regard to platelet activation and aggregation. Furthermore, its aptness extends to the comprehensive exploration of purinergic receptors and their involvement in diverse ailments, namely but not limited to cardiovascular disease and cancer. Alternative Names: 6-Methylthioinosine-5'-triphosphate, Sodium salt; 6-Methylmercapto-9-(β-D-ribofuranosyl)purine-5'-triphosphate. Grades: ≥ 95% by HPLC. CAS No. 51464-82-5. Molecular formula: C11H17N4O13P3S (free acid). Mole weight: 538.25 (free acid). | |
| 6-Methyluridine | 6-Methyluridine is an indispensable nucleoside analog, spearheading innovation in antiviral compound research and development. Alternative Names: 6-Methyl-D-uridine; 4-p-aminobenzenesulphonamidopyridine; 4-amino-N-pyridin-4-yl-benzenesulfonamide; N1-6-methyluridine; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-methylpyrimidine-2,4(1H,3H)-dione; NSC 112513. Grades: ≥95%. CAS No. 16710-13-7. Molecular formula: C10H14N2O6. Mole weight: 258.23. | |
| 6-Monodeoxy-6-monoazido-6-mono-O-(p-toluenesulfonyl)-beta-cyclodextrin | 6-Monodeoxy-6-monoazido-6-mono-O-(p-toluenesulfonyl)-beta-cyclodextrin, a profound compound widely employed in the biomedical sector, has garnered significant attention for its notable role as a drug delivery system. The intricacies surrounding its potential in targeted therapy for diverse ailments have been meticulously examined. Molecular formula: C49H75O36N3S. Mole weight: 1314.18. | |
| 6-Monodeoxy-6-monobromo-beta-cyclodextrin | 6-Monodeoxy-6-monobromo-beta-cyclodextrin is a vital reagent used in the biomedical industry. It has been extensively researched for its potential in drug delivery systems and encapsulation of guest molecules. This modified cyclodextrin plays a crucial role in improving solubility and stability of drugs during formulation. Alternative Names: 6A-Bromo-6A-deoxy-β-cyclodextrin; 6-Deoxy-6-bromo-β-cyclodextrin; 6-Bromo-6-deoxy-β-cyclodextrin; 6-Bromo-6-deoxycyclomaltoheptaose; 6-Bromo-β-cyclodextrin; Mono-6-deoxy-6-bromo-β-cyclodextrin; Mono-(6-bromo-6-deoxy)-beta-cyclodextrin. CAS No. 117240-40-1. Molecular formula: C42H69BrO34. Mole weight: 1197.88. | |
| 6-Monodeoxy-6-monoiodo-beta-cyclodextrin | 6-Monodeoxy-6-monoiodo-beta-cyclodextrin, a groundbreaking and indispensable biomedical compound, revolutionizes the field of drug delivery systems and pharmaceutical formulations. Invaluable for its unrivaled potential, it paves the way for targeted administration of iodine-infused medicinal agents, thereby displaying exceptional prowess in combating a multitude of ailments. The extraordinary structure of this compound bestows upon it the ability to amplify therapeutic effectiveness, while simultanously mitigating the perils of medication-induced toxicity. Alternative Names: 6A-Deoxy-6A-iodo-β-cyclodextrin; 6-Deoxy-6-iodo-β-cyclodextrin; 6-Iodo-6-deoxy-β-cyclodextrin; 6-Iodo-6-deoxycyclomaltoheptaose; 6-Iodo-β-cyclodextrin; Mono-6-deoxy-6-iodo-β-cyclodextrin; Mono-(6-iodo-6-deoxy)-beta-cyclodextrin. CAS No. 29390-66-7. Molecular formula: C42H69IO34. Mole weight: 1244.88. | |
| 6-Monomesyl-gamma-cyclodextrin | 6-Monomesyl-gamma-cyclodextrin is a fundamental constituent in the biomedical field with extensive application in the enrichment of solubility, stability and bioavailability pertaining to inadequately soluble pharmaceutical drugs. Molecular formula: C49H82SO42. Mole weight: 1375.22. | |
| 6-Mono-tert-butyldimethylsilyl-a-cyclodextrin | 6-Mono-tert-butyldimethylsilyl-α-cyclodextrin is a versatile compound functioning as an efficient compound delivery system, enhancing the bioavailability and stability of therapeutic compounds. CAS No. 441764-43-8. Molecular formula: C42H74O30Si. Mole weight: 1087.10. | |
| 6-Mono-tert-butyldimethylsilyl-gamma-cyclodextrin | 6-Mono-tert-butyldimethylsilyl-gamma-cyclodextrin, an immensely versatile compound, finds its application in drug delivery systems and pharmaceutical research. Its profound impact on enhancing the solubility and stability of hydrophobic drugs renders it indispensable in the treatment of an array of diseases, encompassing cancer and microbial infections. Operating as a catalyst for improved drug efficacy, elevated bioavailability, and diminished toxicity, this compound emerges as an invaluable asset in the biomedical industry. Molecular formula: C54H94O40SI. Mole weight: 1542.27. | |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | 6-N-Acyl-6-N-methyl-2'-deoxyadenosine, a potential anti-cancer drug, has exhibited the ability to impede the growth of multiple cancer cell types inclusive of breast, lung, and colon cancer cells. The mechanism of action is believed to entail the inhibition of DNA synthesis and the induction of apoptosis. Further research is currently underway to investigate its viability as a cancer treatment. Grades: ≥ 95%. CAS No. 1377950-60-1. Molecular formula: C13H17N5O4. Mole weight: 307.31. | |
| 6-N-Glycolylneuraminyl-D-lactose sodium salt | 6-N-Glycolylneuraminyl-D-lactose sodium salt. Alternative Names: Neu5Gc-a-2-6-Gal-b-1-4-Glc. | |
| 6'-NH2-Ado | 6'-NH2-Ado is an inhibitor of adenosine kinase. Alternative Names: 6'- Amino- 6'- deoxyadenosine. Grades: ≥ 96% by HPLC. CAS No. 14366-44-7. Molecular formula: C10H14N6O3. Mole weight: 266.3 (free base). | |
| 6-O-(2,3,4,6-Tetra-O-acetyl-a-D-galactopyranosyl)-1,2,3,6-tetra-O-acetyl-b-D-thioglucopyranose | 6-O-(2,3,4,6-Tetra-O-acetyl-α-D-galactopyranosyl)-1,2,3,6-tetra-O-acetyl-β-D-thioglucopyranose is an indispensable biomedical compound, exhibiting remarkable prowess in tackling select enzymes and receptors implicated in diverse pathological mechanisms. Augmented stability attained through acetylation further bolsters its utility, enabling its applications in research of targeting afflictions encompassing cancer, diabetes and infectious ailments. Molecular formula: C26H36O17S. Mole weight: 652.62. | |
| 6-O-(2,3,4,6-Tetra-O-acetyl-a-D-mannopyranosyl)-1,2,3,4-tetra-O-benzyl-a-D-mannopyranoside | 6-O-(2,3,4,6-Tetra-O-acetyl-α-D-mannopyranosyl)-1,2,3,4-tetra-O-benzyl-α-D-mannopyranoside is an intriguing and multifaceted compound, finding significant utility in drug development of targeting select afflictions. Molecular formula: C48H54O15. Mole weight: 870.93. | |
| 6-O-[2-(4-Nitrophenyl)ethyl]-2-(2-furanylmethylamino)-2'-deoxyinosine | 6-O-[2-(4-Nitrophenyl)ethyl]-2-(2-furanylmethylamino)-2'-deoxyinosine, an immensely powerful nucleoside analogue, stands as a quintessential substance extensively employed within the realm of biomedical research. With its profound efficacy in combating specific viral infections, it emerges as an exemplary specimen, streamlining the analysis of viral replication and paving the way for unprecedented therapeutic innovations. Grades: ≥95%. Molecular formula: C23H24N6O7. Mole weight: 496.47. | |
| 6-O-[2-(4-Nitrophenyl)ethyl]-2-[(3-pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine | 6-O-[2-(4-Nitrophenyl)ethyl]-2-[(3-pyridyl)pyrrolidin-1-yl]-2'-deoxyinosine is an invaluable biomedical compound, exhibiting profound significance in the research of various diseases, ranging from formidable adversaries like cancer, viral infections, to complex autoimmune disorders. Grades: ≥95%. Molecular formula: C27H29N7O6. Mole weight: 547.57. | |
| 6-O-[2-Acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-b-D-glucopyranosyl]-D-galactose | 6-O-[2-Acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-b-D-glucopyranosyl]-D-galactose, a highly intricate and complex carbohydrate derivative, is widely utilized within the biomedical field. Renowned for its remarkable potential, this compound plays a pivotal role in the advancement of pharmaceuticals, particularly in combatting a wide array of bacterial infections. By selectively impeding the proliferation of pathogenic bacteria, this unprecedented compound showcases its therapeutic efficacy. Alternative Names: Gal-b-1,4-GlcNAc-b-1,6-Gal; Galactose, O-β-D-galactopyranosyl-(1→4)-O-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→6)-, D-; O-β-D-Galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→6)-D-galactose; Gal(b1-4)GlcNAc(b1-6)aldehydo-Gal. CAS No. 20331-45-7. Molecular formula: C20H35NO16. Mole weight: 545.49. | |
| 6-O-(2-Acetamido-2-deoxy-b-D-glucopyranosyl)-D-galactopyranose | 6-O-(2-Acetamido-2-deoxy-b-D-glucopyranosyl)-D-galactopyranose is a vital compound used in the biomedical industry. It is primarily utilized in pharmaceutical research to develop drugs targeting specific diseases related to carbohydrate metabolism, such as diabetes or glycogen storage diseases. This compound plays a crucial role in understanding and potentially studying these conditions by modulating glucose metabolism and glycosylation pathways. Alternative Names: GlcNAc-b-1,6-Gal. CAS No. 20212-77-5. Molecular formula: C14H25NO11. Mole weight: 383.36. | |
| 6-O-(4,7-Di-O-methyl-N-acetyl-alpha-neuraminosyl)-D-galactopyranoside | 6-O-(4,7-Di-O-methyl-N-acetyl-alpha-neuraminosyl)-D-galactopyranoside. | |
| 6-O-Acetyl-1,2:3,4-di-O-isopropylidene-a-D-galactopyranose | 6-O-Acetyl-1,2:3,4-di-O-isopropylidene-a-D-galactopyranose, an instrumental compound harnessed by the biomedical industry, encompasses multifarious applications. With its integration into the realm of pharmaceuticals, this vital constituent engenders a formidable arsenal of antiviral medications focused on combating influenza, among other targeted ailments. Alternative Names: (4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-8-yl)methyl acetate. CAS No. 4860-78-0. Molecular formula: C14H22O7. Mole weight: 302.32. | |
| 6-O-Acetyl-1,2:3,5-di-O-methylidene-a-D-glucofuranose | 6-O-Acetyl-1,2:3,5-di-O-methylidene-a-D-glucofuranose is an intriguing compound featured in the biomedical realm, exhibiting capacity to impede tumor cell proliferation. Molecular formula: C10H14O7. Mole weight: 246.22. | |
| 6-O-Acetyl-2,3,4-tri-O-benzoyl-b-D-mannopyranose | 6-O-Acetyl-2,3,4-tri-O-benzoyl-b-D-mannopyranose is an esteemed and invaluable compound that finds utility within the research and development of afflictions, inclusive of cancer, bacterial infections and viral maladies. Molecular formula: C29H26O10. Mole weight: 534.51. | |
| 6-O-Acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose | 6-O-Acetyl-2-azido-3,4-di-O-benzyl-2-deoxy-D-glucopyranose, the chemical compound extensively employed in the biomedical industry, showcases an intricately complex structure. This intricate configuration renders it indispensible for the advancement of antiviral medications and immunizations. Alternative Names: D-Glucose, 2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-, 6-acetate. CAS No. 211237-94-4. Molecular formula: C22H25N3O6. Mole weight: 427.46. | |
| 6-O-Acetyldaidzin | 6-O-Acetyldaidzin is an extraordinary biomedical compound, standing at the forefront of studying estrogen-related diseases. This groundbreaking compound, with remarkable active ingredient, unveiling immense potential in thwarting the proliferation of malignant breast cancer cells. Alternative Names: Daidzin 6-O-acetate. CAS No. 71385-83-6. Molecular formula: C23H22O10. Mole weight: 458.41. | |
| 6-O-Acetyl-D-glucopyranose | 6-O-Acetyl-D-glucopyranose. CAS No. 118759-70-9. Molecular formula: C8H14O7. Mole weight: 222.19. | |
| 6-O-Acetylgenistin | 6-O-Acetylgenistin, a natural compound employed in biomedicine, emerges as a compelling option due to its multifaceted attributes. Derived from Genistin, this substance offers potential therapeutic effects on diverse diseases. Recent research studies underscore its anti-inflammatory and antioxidant properties, thus positioning it as a promising contender in combating chronic inflammatory conditions, cardiovascular ailments, and cancer. The pharmacological attributes showcased by 6-O-Acetylgenistin render it indispensable in the realm of drug development targeting these afflictions. Alternative Names: Genistin 6-O-acetate. CAS No. 73566-30-0. Molecular formula: C23H22O11. Mole weight: 474.41. | |
| 6-O-Acetylpaniculoside II | 6-O-Acetylpaniculoside II. | |
| 6-O-(a-D-Galactopyranosyl)-b-D-thioglucopyranose | 6-O-(a-D-Galactopyranosyl)-b-D-thioglucopyranose is a pharmaceutical compound of significant magnitude, finding favorable outcomes in research of various diseases, particularly those associated with carbohydrate metabolism and glycosylation disorders. Molecular formula: C12H22O10S. Mole weight: 358.36. | |
| 6-O-(a-D-Galactopyranosyl)-D-galactopyranose | 6-O-(a-D-Galactopyranosyl)-D-galactopyranose is a prominent molecule, playing a pivotal role in studying galactose metabolic intricacies. Leveraging its distinct composition, this remarkable entity showcases immense potential for propelling the field of galactose-mediated research, encompassing galactosemia and its correlated ailments. Alternative Names: 6-O-alpha-D-galactopyranosyl-D-galactopyranose; alpha-Gal-(1-6)-Gal; alpha-D-Gal-(1->6)-D-Gal; alpha-D-Galp-(1->6)-D-Galp; alpha-D-galactosyl-(1->6)-D-galactose; alpha-D-galactopyranosyl-(1->6)-D-galactopyranose; Galalpha1-6Gal. CAS No. 902-54-5. Molecular formula: C12H22O11. Mole weight: 342.30. | |
| 6-O-(a-D-Galactopyranosyl)-D-mannopyranose | 6-O-(α-D-Galactopyranosyl)-D-mannopyranose is a vital natural carbohydrate utilized in the biomedical industry as a building block for synthesizing glycoconjugates. These glycoconjugates are extensively employed in the development of therapeutic compounds for studying various diseases, including cancer, infectious diseases and autoimmune disorders. Molecular formula: C12H22O11. Mole weight: 342.30. | |
| 6-O-a-D-Glucosyl-a-cyclodextrin | 6-O-a-D-Glucosyl-a-cyclodextrin is a highly regarded pharmaceutical-grade compound, functioning as an exceptional compound delivery system. It exudes the power to augment drug solubility and stability. Alternative Names: O-α-D-Glucopyranosyl-(1→6A)-α-cyclodextrin; 6-O-(α-Glucopyranosyl)-α-cyclodextrin; 6-O-α-D-Glucopyranosylcyclomaltohexaose; 6-O-α-D-Glucosyl-α-cyclodextrin; Glucosyl-α-cyclodextrin; α-Glucosyl-α-cyclodextrin. CAS No. 10058-19-2. Molecular formula: C42H70O35. Mole weight: 1134.98. | |
| 6-O-(a-D-Maltotriosyl)-D-glucopyranose | 6-O-(α-D-Maltotriosyl)-D-glucopyranose, an extensively studied compound in biomedicine, holds paramount significance in the advancement of therapeutic interventions. Its pivotal role encompasses the development of novel drugs aimed at combatting diverse ailments. Through meticulous investigations, this product has unveiled its potential therapeutic virtues in addressing the complex pathologies of diabetes, cardiovascular disorders, and metabolic syndromes. Alternative Names: 4-O-[4-O-(6-O-a-D-Glucopyranosyl-a-D-glucopyranosyl)-a-D-glucopyranosyl)-D-glucopyranose; Glc-a-1,4-Glc-a-1,4-Glc-a-1,6-Glc; Glucopyranose, O-α-D-glucopyranosyl-(1→6)-O-α-D-glucopyranosyl-(1→4)-O-α-D-glucopyranosyl-(1→4)-, α-D-; O-α-D-Glucopyranosyl-(1→6)-O-α-D-glucopyranosyl-(1→4)-O-α-D-glucopyranosyl-(1→4)-α-D-glucopyranose. CAS No. 13264-95-4. Molecular formula: C24H42O21. Mole weight: 666.59. | |
| 6-O-(a-D-Maltotriosyl)-D-glucopyranose tetradecaacetate | 6-O-(a-D-Maltotriosyl)-D-glucopyranose tetradecaacetate is a biomedical compound of paramount significance which can selectively modulate distinct biochemical cascades. Molecular formula: C52H70O35. Mole weight: 1255.09. | |
| 6-O-(a-D-Mannopyranosyl)-D-mannose | It is used as an antimicrobial agent against Escherichia coli. Alternative Names: 6-O-α-D-Mannopyranosyl-D-mannose; Mannose, 6-O-α-D-mannopyranosyl-; Mannose, 6-O-α-D-mannopyranosyl-, D-; α1-6 Mannobiose; 6-O-α-Mannobiose; α-(1→6)-Mannobiose; α-D-Man-(1→6)-D-Man. Grades: ≥95%. CAS No. 6614-35-3. Molecular formula: C12H22O11. Mole weight: 342.30. | |
| 6-O-α-D-Glucosyl-β-cyclodextrin | 6-O-α-D-Glucosyl-β-cyclodextrin is an extraordinary compound serving as an invaluable asset for precise drug conveyance and localization. Exhibiting unparalleled architecture, it proficiently enwraps hydrophobic pharmaceuticals, thereby amplifying their dissolution, constancy is and accessibility. Its remarkable proficiency manifesting in the efficacious research of a multitude of ailments encompassing neoplastic afflictions, infectious maladies is and intricate neurologic conditions. Alternative Names: 6-O-alpha-D-Glucosyl-beta-cyclodextrin; 6-O-a-D-Glucosyl-b-cyclodextrin; O-α-D-Glucopyranosyl-(1→6A)-β-cyclodextrin. CAS No. 92517-02-7. Molecular formula: C48H80O40. Mole weight: 1297.13. | |
| 6-O-α-D-Maltosyl-β-cyclodextrin | 6-O-α-D-Maltosyl-β-cyclodextrin is a cellular cholesterol modifier which can form soluble inclusion complex with cholesterol and is much less cytotoxic to human erythrocytes and Caco-2 cells. Grades: >98%. CAS No. 104723-60-6. Molecular formula: C54H90O45. Mole weight: 1459.27. | |
| 6-O-b-D-Galactosylsucrose | 6-O-b-D-Galactosylsucrose, a compound employed in scientific investigations concerning glycoside hydrolase enzymes and their impact on carbohydrate metabolism. This substance exhibits promise in the realm of drug innovation for treating metabolic disorders and diabetes, showcasing potential for therapeutic advancements. Alternative Names: SCHEMBL4808619; (2R,3R,4S,5S,6R)-2-(((2S,3S,4S,5R)-3,4-Dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-6-((((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol. CAS No. 41545-69-1. Molecular formula: C18H32O16. Mole weight: 504.4. | |
| 6-O-Benzoyl-1,2,3-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-benzyl-a-D-galactopyranosyl)-b-D-galactopyranoside | 6-O-Benzoyl-1,2,3-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-benzyl-a-D-galactopyranosyl)-b-D-galactopyranoside is a compound widely exploited in the biomedical domain, showcasing significant complexity in research of diverse ailments, most notably cancer. Alternative Names: Benzyl 4-O-(2,3,4,6-tetra-O-benzyl-a-D-galactopyranosyl)-2,3-di-O-benzyl-6-O-benzoyl-b-D-galactopyranoside. Molecular formula: C68H68O12. Mole weight: 1077.26. | |
| 6-O-Benzoyl-2,3,6,3,4-penta-O-acetyl-sucrose | 6-O-Benzoyl-2,3,6,3,4-penta-O-acetyl-sucrose. | |
| 6-O-Benzoyl-3-O-benzyl-1,2-O-isopropylidene-5-O-mesyl-α-D-glucofuranose | 6-O-Benzoyl-3-O-benzyl-1,2-O-isopropylidene-5-O-mesyl-α-D-glucofuranose. Alternative Names: 1,2-O-(1-Methylethylidene)-3-O-(phenylmethyl)-α-D-glucofuranose 6-benzoate 5-methanesulfonate. CAS No. 134198-40-6. Molecular formula: C24H28O9S. Mole weight: 492.57. | |
| 6-O-Benzoyl-3-O-tert-butyldimethylsilyl-D-galactal | 6-O-Benzoyl-3-O-tert-butyldimethylsilyl-D-galactal is an organic compound with remarkable versatility, finding profound utility in the development of therapeutic compounds designed to combat a myriad of afflictions. Molecular formula: C19H28O5Si. Mole weight: 364.51. | |
| 6-O-Benzoyl-3-O-tert-butyldimethylsilyl-D-glucal | 6-O-Benzoyl-3-O-tert-butyldimethylsilyl-D-glucal is an indispensable intermediary compound in the development of antiviral pharmaceuticals and the research of a plethora of viral infections encompassing HIV, herpes and influenza. Molecular formula: C19H28O5Si. Mole weight: 364.51. | |
| 6-O-Benzoyl-3-O-tert-butyldiphenylsilyl-D-galactal | 6-O-Benzoyl-3-O-tert-butyldiphenylsilyl-D-galactal is a compound assuming an essential role in pharmaceuticals development and modification. By augmenting compound potency and efficacy, this compound profoundly impacts the research of diverse ailments, including cancer and bacterial infections. Molecular formula: C29H32O5Si. Mole weight: 488.65. | |
| 6-O-Benzoyl-3-O-tert-butyldiphenylsilyl-D-glucal | 6-O-Benzoyl-3-O-tert-butyldiphenylsilyl-D-glucal is a highly esteemed compound assuming a pivotal function in the research and development of pharmaceuticals, specifically tailored to combat a plethora of afflictions including cancer, diabetes and inflammation. Molecular formula: C29H32O5Si. Mole weight: 488.66. | |
| 6-O-Benzoyl-3-O-triisopropylsilyl-D-galactal | 6-O-Benzoyl-3-O-triisopropylsilyl-D-galactal is an imperative compound which has proven to be pivotal for synthesizing diverse pharmaceuticals. Its versatility as an intermediate facilitates the research and development of groundbreaking compounds targeting ailments ranging from cancer to cardiovascular disorders and neurological conditions. Molecular formula: C22H34O5Si. Mole weight: 406.59. | |
| 6-O-Benzoyl-3-O-triisopropylsilyl-D-glucal | 6-O-Benzoyl-3-O-triisopropylsilyl-D-glucal is a remarkable compound extensively employed in the research and development of pharmacological drugs for an array of ailments, embracing the domains of diabetes, cancer and cardiovascular disorders. Molecular formula: C22H34O5Si. Mole weight: 406.59. | |
| 6-O-Benzoyl-D-glucal | 6-O-Benzoyl-D-glucal, an indispensable chemical compound in the biomedical sector, demonstrates profound significance for synthesizing diverse pharmaceutical remedies. Its intricate framework and distinct attributes render it a potential breakthrough in combating ailments like cancer, diabetes, and inflammation. Alternative Names: 6-O-benzoylglucal; D-arabino-Hex-1-enitol, 1,5-anhydro-2-deoxy-, 6-benzoate; N-(6-aminopyridin-2-yl)-2,2-dimethylpropionamide. CAS No. 58871-05-9. Molecular formula: C13H14O5. Mole weight: 250.25. | |
| 6-O-Benzyl-1-(-)-carboxymenthyl-2,3;4,5-di-O-cyclohexylidene-D-myo-inositol | 6-O-Benzyl-1-(-)-carboxymenthyl-2,3;4,5-di-O-cyclohexylidene-D-myo-inositol, a paramount compound within the biomedical sector, exhibits profound therapeutic potential in combating a diverse array of maladies - encompassing diabetes, cancer, and metabolic disorders. The intricate arrangement of its constituents, coupled with its distinctive molecular attributes, render it an invaluable asset in the realm of pharmaceutical innovation. CAS No. 190513-83-8. Molecular formula: C36H52O8. Mole weight: 612.79. | |
| 6-O-Benzyl-1-(-)-carboxymenthyl-2,3:4,5-di-O-cyclohexylidene-L-myo-inositol | 6-O-Benzyl-1-(-)-Carboxymenthyl-2,3:4,5-di-O-cyclohexylidene-L-myo-inositol, a profoundly intricate and scientifically advanced biomedicine, exhibits extensive utilization in the therapeutic intervention of diverse ailments. Its multifaceted attributes render it an eminent pharmacological agent for combating insulin resistance and type 2 diabetes. By virtue of its targeted mode of action, it efficaciously ameliorates glucose metabolism, attenuates blood glucose levels, and enhances insulin sensitivity. CAS No. 190513-80-5. Molecular formula: C36H52O8. Mole weight: 612.79. | |
| 6-O-Benzyl-2,3:4,5-di-O-cyclohexylidene-D-myo-inositol | 6-O-Benzyl-2,3:4,5-di-O-cyclohexylidene-D-myo-inositol is a key compound used in the biomedical industry. It exhibits potent antiviral activity against a wide range of viruses, including HIV and influenza. Additionally, it shows promising potential in the treatment of diabetes and cancer due to its antiproliferative properties. Its diverse applications make it a valuable tool for drug development and research in the field of biomedicine. Alternative Names: 4-O-Benzyl-1,2:5,6-Di-o-Cyclohexylidene-L-Myo-Inositol. CAS No. 124601-98-5. Molecular formula: C25H34O6. Mole weight: 430.53. | |
| 6-O-Benzyl-2,3:4,5-di-O-cyclohexylidene-L-myo-inositol | 6-O-Benzyl-2,3:4,5-di-O-cyclohexylidene-L-myo-inositol, known for its intricate and sophisticated architecture, represents a remarkable chemical entity extensively employed in the realm of biomedical sciences. Renowned for its immense therapeutic promise, this compound exhibits exceptional potential in combatting select malignancies and metabolic irregularities. Its unparalleled structural attributes render it an excellent contender for targeted conveyance of medicinal agents. CAS No. 129094-34-4. Molecular formula: C25H34O6. Mole weight: 430.53. | |
| 6-O-Benzyl-2,3-di-O-acetyl-methyl-a-D-glucopyranoside | 6-O-Benzyl-2,3-di-O-acetyl-methyl-a-D-glucopyranoside, an intricate and multifaceted biomedicine, has captivated the attention of researchers and developers in the esteemed biomedical industry. Marked with promise, this compound has displayed intriguing potential in the exploration of a plethora of ailments, ranging from cancer to diabetes and inflammation. Alternative Names: Methyl 6-O-(phenylmethyl)-a-D-glucopyranoside 2,3-diacetate; α-D-Glucopyranoside, methyl 6-O-(phenylmethyl)-, 2,3-diacetate. CAS No. 162284-50-6. Molecular formula: C18H24O8. Mole weight: 368.38. | |
| 6-O-Benzyl-D-glucal | 6-O-Benzyl-D-glucal is a key component in the biomedical industry used in the research and development of pharmaceutical drugs, such as antiviral drugs and anticancer drugs. CAS No. 165524-85-6. Molecular formula: C13H16O4. Mole weight: 236.26. | |
| 6-O-Benzyl-D-glucose | 6-O-Benzyl-D-glucose, a remarkable compound, finds paramount application in the biomedical field due to its prodigious potential in the advancement of antiviral pharmaceuticals. Its efficacy in thwarting viral replication and combating various viral infections, such as influenza, has been particularly auspicious. Extensive research has underscored its exquisite capability to selectively target viral enzymes, rendering it an auspicious contender for forthcoming antiviral therapies. Alternative Names: 6-O-(Phenylmethyl)-D-glucose; D-Glucose, 6-O-(phenylmethyl)-; D-Glucose, 6-O-benzyl-. CAS No. 22170-16-7. Molecular formula: C13H18O6. Mole weight: 270.28. | |
| 6-O-Benzyl-D-mannose | 6-O-Benzyl-D-mannose, a compound of utmost significance in the biomedical realm, unveils its indispensable character within various maladies' management, encompassing cancer and infectious diseases. Exhibiting both formidable antimicrobial and anti-tumorous potencies, this entity emerges as an auspicious contender for pharmaceutical advancements. Enclosing exceptional therapeutic potential and boasting encouraging outcomes in preclinical assessments, its idiosyncratic architecture and mechanism of efficacy firmly establish its indispensable standing in pioneering drug exploration and therapeutic modalities across the biomedicine landscape. Molecular formula: C13H18O6. Mole weight: 270.28. | |
| 6''-O-(β-D-Galactopyranosyl)-D-maltotriose | 6''-O-(β-D-Galactopyranosyl)-D-maltotriose. Alternative Names: O-β-D-Galactopyranosyl-(1→6)-O-α-D-glucopyranosyl-(1→4)-O-α-D-glucopyranosyl-(1→4)-D-glucose; 6''-O-β-D-Galacosylmaltotriose; 6''-β-D-Galactopyranosyl maltotriose; 6''-β-Galacosylmaltotriose; 6''-O-(α-D-Galactopyranosyl)-D-maltotriose; β-D-Gal-(1-6)-α-D-Glc-(1-4)-α-D-Glc-(1-4)-D-Glc; Galβ1-6Glcα1-4Glcα1-4Glc. Grades: ≥95%. CAS No. 226923-86-0. Molecular formula: C24H42O21. Mole weight: 666.58. | |
| 6-(O-(Carboxymethyl))-2,7-dichlorofluoroscein 3-(O-(N-acetyl-b-D-glucosamide)) | 6-(O-(Carboxymethyl))-2,7-dichlorofluoroscein 3-(O-(N-acetyl-b-D-glucosamide)) is a vital tool in the biomedical industry used in drug discovery and development processes, making it an excellent choice for identifying and tracking specific drug targets or biomolecules involved in diseases like cancer, diabetes and neurodegenerative disorders. With its high sensitivity and specificity, it facilitates the understanding of drug mechanisms and disease progression. Alternative Names: CM-DCF-NAG; 2-(3'-((2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2',7'-dichloro-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthene]-6'-yloxy)acetic acid; [[6'-[[2-(Acetylamino)-2-deoxy-β-D-glucopyranosyl]oxy]-2',7'-dichloro-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3'-yl]oxy]acetic acid; 6'-(O-(Carboxymethyl))-2',7'-dichlorofluoroscein 3'-(O-(N-acetyl-b-D-glucosamide)). CAS No. 732962-21-9. Molecular formula: C30H25Cl2NO12. Mole weight: 662.44. | |
| 6-O-(D,L-1-Ethoxyethyl)-1,2:4,5-bis-O-(1-methylethylidene) D,L-myo-Inositol | 6-O-(D,L-1-Ethoxyethyl)-1,2:4,5-bis-O-(1-methylethylidene) D,L-myo-Inositol is a compound useful in organic synthesis. CAS No. 197848-74-1. Molecular formula: C16H28O7. Mole weight: 332.39. | |
| 6-O-Ethylguanosine | 6-O-Ethylguanosine is a guanosine derivative and have been studied as potential covalent carcinogenic lesions in DNA. Alternative Names: O6-Ethylguanosine. CAS No. 39708-01-5. Molecular formula: C12H17N5O5. Mole weight: 311.29. | |
Our database is helping our users find suppliers everyday.
